Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.